Faculty

Senior Associate Dean for Postgraduate Medical Education

Director, Master in Medical Sciences in Clinical Investigation (MMSCI) Program

Harvard Medical School

Cambridge, Massachusetts

Clinical Professor of Medicine

University of Illinois at Chicago

Chicago, Illinois

Professor of Clinical Medicine

Indiana University School of Medicine

Chief Medical Officer for Outpatient Dialysis

Indiana University Health

Indianapolis, Indiana

Program Overview

Relatively recent advancements in the understanding of the pathophysiology of CKD-associated anemia has led to the discovery of viable treatment targets, yet nephrologists may lack awareness of these therapeutic developments. Additionally, certain healthcare disparities may limit comprehensive management across the broader population of patients with anemia and CKD, consequently increasing the global burden of this complication. To ensure appropriate care and outcomes for patients, nephrologists require up-to-date education on the pathophysiology of anemia and CKD, burden of disease, current and emerging treatment options, and barriers to care.

Target Audience

[email protected]

Ushering in a New Era in the Treatment of Chronic Kidney Disease and Anemia: Appreciating The Patient Burden, Exploring Pathways and Pathogenesis, Reflecting on the New and Emerging Data

Faculty

Ajay K. Singh MBBS, FRCP (UK), MBA (Chair)

Edgar V. Lerma, MD

Jay B. Wish, MD

Program Overview

Target Audience

MODULE ONE

Prevalence & Burden of Anemia in CKD

MODULE TWO

Pathogenesis of CKD Anemia & New Pathways

MODULE THREE

Emerging Agents Targeting HIF

MODULE FOUR

Patient-Centered Care in the Treatment of CKD Anemia